Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019)

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR) – EClinicalMedicine

Commentary on Twitter

Great paper with lots of interesting data. What strikes me most: the drawbacks (retaliation) the clinicians experienced who reported the severe adverse drug reactions (several were sued by Big Pharma, one lost his professorship)https://t.co/NimX0rnsAt

— Michael P. Hengartner, PhD (@HengartnerMP) December 26, 2020